Zhou J[au] - Search Results

Year	Number of Results
1965	1
1979	2
1980	6
1981	16
1982	10
1983	15
1984	16
1985	16
1986	15
1987	30
1988	41
1989	39
1990	38
1991	43
1992	70
1993	85
1994	89
1995	101
1996	135
1997	155
1998	122
1999	170
2000	180
2001	231
2002	241
2003	332
2004	434
2005	565
2006	698
2007	813
2008	867
2009	1043
2010	1159
2011	1372
2012	1651
2013	1988
2014	2256
2015	2581
2016	2683
2017	3019
2018	3391
2019	4044
2020	4818
2021	5409
2022	6475
2023	6280
2024	6602
2025	83

1

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.

Qi C, Gong J, Li J, Liu D, Qin Y, Ge S, Zhang M, Peng Z, Zhou J, Cao Y, Zhang X, Lu Z, Lu M, Yuan J, Wang Z, Wang Y, Peng X, Gao H, Liu Z, Wang H, Yuan D, Xiao J, Ma H, Wang W, Li Z, Shen L. Qi C, et al. Among authors: zhou j. Nat Med. 2022 Jun;28(6):1189-1198. doi: 10.1038/s41591-022-01800-8. Epub 2022 May 9. Nat Med. 2022. PMID: 35534566 Free PMC article. Clinical Trial.

2

Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.

Wang Q, Zhou H, Bu Q, Wei S, Li L, Zhou J, Zhou S, Su W, Liu M, Liu Z, Wang M, Lu L. Wang Q, et al. Among authors: zhou j. J Hepatol. 2022 Aug;77(2):312-325. doi: 10.1016/j.jhep.2022.02.031. Epub 2022 Mar 12. J Hepatol. 2022. PMID: 35292349 Free article.

3

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.

Wei CY, Zhu MX, Zhang PF, Huang XY, Wan JK, Yao XZ, Hu ZT, Chai XQ, Peng R, Yang X, Gao C, Gao J, Wang SW, Zheng YM, Tang Z, Gao Q, Zhou J, Fan JB, Ke AW, Fan J. Wei CY, et al. Among authors: zhou j. J Hepatol. 2022 Jul;77(1):163-176. doi: 10.1016/j.jhep.2022.02.019. Epub 2022 Feb 24. J Hepatol. 2022. PMID: 35219791 Free article.

4

ETS1 acts as a regulator of human healthy aging via decreasing ribosomal activity.

Xiao FH, Yu Q, Deng ZL, Yang K, Ye Y, Ge MX, Yan D, Wang HT, Chen XQ, Yang LQ, Yang BY, Lin R, Zhang W, Yang XL, Dong L, He Y, Zhou J, Cai WW, Li J, Kong QP. Xiao FH, et al. Among authors: zhou j. Sci Adv. 2022 Apr 29;8(17):eabf2017. doi: 10.1126/sciadv.abf2017. Epub 2022 Apr 27. Sci Adv. 2022. PMID: 35476452 Free PMC article.

5

Long-Term Body Mass Index Variability and Adverse Cardiovascular Outcomes.

Almuwaqqat Z, Hui Q, Liu C, Zhou JJ, Voight BF, Ho YL, Posner DC, Vassy JL, Gaziano JM, Cho K, Wilson PWF, Sun YV. Almuwaqqat Z, et al. Among authors: zhou jj. JAMA Netw Open. 2024 Mar 4;7(3):e243062. doi: 10.1001/jamanetworkopen.2024.3062. JAMA Netw Open. 2024. PMID: 38512255 Free PMC article.

6

Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma.

Lu Z, Liu R, Wang Y, Jiao M, Li Z, Wang Z, Huang C, Shi G, Ke A, Wang L, Fu Y, Xia J, Wen H, Zhou J, Wang X, Ye D, Fan J, Chu Y, Cai J. Lu Z, et al. Among authors: zhou j. Hepatology. 2023 Mar 1;77(3):745-759. doi: 10.1002/hep.32442. Epub 2023 Feb 17. Hepatology. 2023. PMID: 35243663

7

Network Pharmacology Study and Experimental Validation of Yiqi Huayu Decoction Inducing Ferroptosis in Gastric Cancer.

Song S, Wen F, Gu S, Gu P, Huang W, Ruan S, Chen X, Zhou J, Li Y, Liu J, Shu P. Song S, et al. Among authors: zhou j. Front Oncol. 2022 Feb 14;12:820059. doi: 10.3389/fonc.2022.820059. eCollection 2022. Front Oncol. 2022. PMID: 35237519 Free PMC article.

8

The effects of aligner overtreatment on torque control and intrusion of incisors for anterior retraction with clear aligners: A finite-element study.

Liu L, Song Q, Zhou J, Kuang Q, Yan X, Zhang X, Shan Y, Li X, Long H, Lai W. Liu L, et al. Among authors: zhou j. Am J Orthod Dentofacial Orthop. 2022 Jul;162(1):33-41. doi: 10.1016/j.ajodo.2021.02.020. Epub 2022 Feb 23. Am J Orthod Dentofacial Orthop. 2022. PMID: 35219555

9

Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma.

Chen S, Zhang P, Zhu G, Wang B, Cai J, Song L, Wan J, Yang Y, Du J, Cai Y, Zhou J, Fan J, Dai Z. Chen S, et al. Among authors: zhou j. Cell Mol Immunol. 2024 Dec;21(12):1505-1521. doi: 10.1038/s41423-024-01231-0. Epub 2024 Nov 4. Cell Mol Immunol. 2024. PMID: 39496854

10

Lactylation of NAT10 promotes N⁴-acetylcytidine modification on tRNA^Ser-CGA-1-1 to boost oncogenic DNA virus KSHV reactivation.

Yan Q, Zhou J, Gu Y, Huang W, Ruan M, Zhang H, Wang T, Wei P, Chen G, Li W, Lu C. Yan Q, et al. Among authors: zhou j. Cell Death Differ. 2024 Oct;31(10):1362-1374. doi: 10.1038/s41418-024-01327-0. Epub 2024 Jun 15. Cell Death Differ. 2024. PMID: 38879723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,253 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54,253 results

Results by year